pharmacie et médicaments – Baisse des remises génériques pour les pharmacies d'officine

This written question concerns the reduction of generic drug rebates for retail pharmacies in France. It seeks clarification on the potential impact of these changes on pharmacy operations and the accessibility of medicines. The question addresses the financial implications for pharmacies and the broader healthcare system. It aims to understand how these policy adjustments might affect the cost and availability of essential medications for patients.